1. Home
  2. FNB vs GKOS Comparison

FNB vs GKOS Comparison

Compare FNB & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo F.N.B. Corporation

FNB

F.N.B. Corporation

HOLD

Current Price

$16.17

Market Cap

5.7B

Sector

Finance

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$103.63

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNB
GKOS
Founded
1864
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
6.0B
IPO Year
2001
2015

Fundamental Metrics

Financial Performance
Metric
FNB
GKOS
Price
$16.17
$103.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
14
Target Price
$19.10
$133.07
AVG Volume (30 Days)
7.9M
591.7K
Earning Date
04-15-2026
04-29-2026
Dividend Yield
2.90%
N/A
EPS Growth
22.83
N/A
EPS
1.56
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
$14.53
$23.34
Revenue Next Year
$7.90
$27.46
P/E Ratio
$10.59
N/A
Revenue Growth
N/A
32.33
52 Week Low
$10.93
$73.16
52 Week High
$19.14
$130.23

Technical Indicators

Market Signals
Indicator
FNB
GKOS
Relative Strength Index (RSI) 40.54 44.08
Support Level $15.81 $94.92
Resistance Level $16.27 $104.66
Average True Range (ATR) 0.36 4.03
MACD 0.07 0.64
Stochastic Oscillator 50.00 54.14

Price Performance

Historical Comparison
FNB
GKOS

About FNB F.N.B. Corporation

F N B Corp provides a full range of financial services, principally to consumers, corporations, governments, and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management, and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: